GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells

SKU:BHT2200017
Research Validated
Overview
Click light‑blue chips for details
GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells is a SignaGen Laboratories reagent pre-optimized for plasmid DNA delivery into HepG2 cells, so the usual optimization step is not needed. HepG2, a well-characterized human hepatocellular carcinoma line, was taken from liver tissue of a 15-year-old male donor whose hepatocellular carcinoma was differentiated.
Transfection Type DNA Transfection
Application Setting In Vitro
Optimized Cell Line HepG2
Storage 4 °C
Shelf Life 24 months
Options selector
Catalog no. Size
SL100489-HEPG2-0P1ML 0.1 mL
SL100489-HEPG2-0P5ML 0.5 mL
SL100489-HEPG2-1P0ML 1.0 mL
SL100489-HEPG2-1P0MLX5 1.0 mL x 5
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: 4 variants available — select size from the variant selector.
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Store at 4°C. When maintained under the recommended storage conditions, the product remains stable for at least 24 months.
  • Shipping: Please contact us to confirm shipping conditions for this product.
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Storage 4 °C
Catalog no. (Mfr.) SL100489-HEPG2
Main SKU BHT2200017

Product Overview

HepG2, a well-characterized human hepatocellular carcinoma line, was taken from liver tissue of a 15-year-old male donor whose hepatocellular carcinoma was differentiated. Epithelial morphology and the retention of many liver-specific functions have pushed the line to the front rank of in vitro models for hepatic metabolism, gene regulation, drug discovery, toxicology, viral infection, and recombinant protein expression. Plasma proteins synthesized and secreted by HepG2 cells include albumin, transferrin, α1-antitrypsin, α2-macroglobulin, and plasminogen, and the cells answer a variety of hormonal and metabolic stimuli.

Robust growth characteristics plus adaptability to large-scale culture systems have widened their use further across biomedical and pharmaceutical research. GenJet™ DNA In Vitro Transfection Reagent for HepG2 Cells comes tuned to the line, delivering plasmid DNA into HepG2 cells efficiently.

Specifications

Transfection Type DNA Transfection
Application Setting In Vitro
Pre-Optimized Yes — Pre-Optimized for Specific Cell Type
Optimized Cell Line HepG2
Storage Store at 4°C. When maintained under the recommended storage conditions, the product remains stable for at least 24 months.

Kit Contents

One milliliter of GenJet™ Reagent is sufficient for approximately 300–600 transfections in 24-well plates or 50–100 transfections in 6-well plates, depending on the culture format and amount of DNA used.

Performance Data

GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells – HepG2 GFP transfection vs L2K and Amaxa®; serum/antibiotic effect
GenJet™ Reagent is specifically optimized for HepG2 cells (ATCC® HB-8065™) and demonstrates superior transfection performance compared with Lipofectamine™ 2000 (L2K) and the Amaxa® electroporation system. HepG2 cells were cultured according to ATCC-recommended conditions on collagen type I–coated culture dishes and transfected with the GFP reporter plasmid pEGFP-N3. Transfection efficiency was evaluated 48 hours post-transfection. Right Panel: Comparison of transfection efficiencies achieved with GenJet™, Lipofectamine™ 2000 (L2K), and the Amaxa® electroporation system in HepG2 cells. A 4.7-kb GFP expression plasmid (pEGFP-N3) was delivered into HepG2 cells cultured on collagen-coated dishes according to each manufacturer’s recommended protocol. Transfection efficiency, expressed as the percentage of GFP-positive cells, and GFP fluorescence intensity were quantified by flow cytometry (FACS) 48 hours post-transfection. Left Panel: Effect of serum and antibiotics on GenJet™-mediated transfection in HepG2 cells. Cells cultured on collagen-coated dishes were transfected under three different conditions: (1) serum- and antibiotic-free medium; (2) medium containing 10% serum and antibiotics, followed by medium replacement 5 hours post-transfection; and (3) medium containing 10% serum and antibiotics without medium replacement following transfection. The presence of serum and antibiotics was found to enhance GenJet™-mediated gene delivery and transgene expression in HepG2 cells.
GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells – GFP and β-galactosidase expression in HepG2 cells
Representative images demonstrating the transfection performance of the pre-optimized GenJet™ DNA Transfection Reagent in HepG2 cells (ATCC® HB-8065™). HepG2 cells were cultured under ATCC-recommended conditions on collagen type I–coated culture dishes and transfected with either the GFP reporter plasmid pEGFP-N3 (4.7 kb; right panel) or the β-galactosidase expression plasmid pSV-β-galactosidase (6.9 kb; left panel). Transgene expression was evaluated 48 hours post-transfection by confocal fluorescence microscopy using a Zeiss LSM 510 system for GFP detection and by β-galactosidase staining for assessment of β-galactosidase expression. The results demonstrate efficient delivery and expression of both reporter genes in HepG2 cells.

Applications

This DNA transfection reagent supports a range of molecular biology applications including transient and stable transfection, reporter assays, protein expression studies, and gene function analysis in mammalian cell systems.

Safety & Handling

For Research Use Only (RUO) — Not for diagnostic or therapeutic use. Handle reagents according to institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.
Q.What cell types are compatible with GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells?
A.This reagent is designed for broad compatibility with mammalian cell lines. It is pre-optimized for HepG2 cells for maximum efficiency. SignaGen offers pre-optimized versions for specific cell types.
Q.How should I store GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells?
A.Store at 4°C. When maintained under the recommended storage conditions, the product remains stable for at least 24 months. Follow the product datasheet for detailed storage and stability information.
Q.Do I need to optimize transfection conditions with this product?
A.No. GenJet™ In Vitro DNA Transfection Reagent for HepG2 Cells is pre-optimized for HepG2 cells, so optimization is not required. Follow the provided protocol for best results.
Q.How many transfections does one vial provide?
A.One milliliter of GenJet™ Reagent is sufficient for approximately 300–600 transfections in 24-well plates or 50–100 transfections in 6-well plates, depending on the culture format and amount of DNA used. Actual numbers depend on plate format and the amount of nucleic acid used.
Q.What are HepG2 cells?
A.HepG2, a well-characterized human hepatocellular carcinoma line, was taken from liver tissue of a 15-year-old male donor whose hepatocellular carcinoma was differentiated. Epithelial morphology and the retention of many liver-specific functions have pushed the line to the front rank of in vitro models for hepatic metabolism, gene regulation, drug discovery, toxicology, viral infection, and recombinant protein expression.
Q.Is this product suitable for diagnostic or therapeutic use?
A.No. This product is for Research Use Only (RUO) and is not intended for diagnostic, therapeutic, or clinical applications.

Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Du J, Liao W, Wang H, et al.. MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration. Signal Transduct Target Ther (2023) 8(1), 351-351.. 10.1038/s41392-023-01575-5

Zhang X, McGinnis C, Yu G, et al.. Erythropoietin receptor on cDC1s dictates immune tolerance. Nature (2025). 10.1038/s41586-025-09824-z

Lee M, Siddoway B, Kaeser G, et al.. Somatic APP gene recombination in Alzheimer's disease and normal neurons. Nature (2018) 563(7733), 639-645.. 10.1038/s41586-018-0718-6

Konermann S, Brigham M, Trevino A, et al.. Optical control of mammalian endogenous transcription and epigenetic states. Nature (2013) 500(7463), 472-476.. 10.1038/nature12466

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today